Skip to main content
SpringerLink
Log in

Acarbose/metformin/repaglinide

Hypoglycaemia: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Du G, et al. Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: A retrospective cohort study. PeerJ 8: 2020. Available from: URL: http://doi.org/10.7717/peerj.9905

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acarbose/metformin/repaglinide. Reactions Weekly 1833, 11 (2020). https://doi.org/10.1007/s40278-020-86829-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-86829-y

Search

Navigation